Home › Acute biphenotypische leukemie › Michigan

Acute biphenotypische leukemie klinische studies in Michigan

4 studies voor Acute biphenotypische leukemie zoeken deelnemers op locaties in Michigan.

Steden in Michigan

Officiële studietekst (Engels)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

C S Mott Children's Hospital, Ann Arbor
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Bronson Methodist Hospital, Kalamazoo

RekruterenFase 2

365 Days · Alle geslachten · Bijgewerkt 25 sep. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

C S Mott Children's Hospital, Ann Arbor
Children's Hospital of Michigan, Detroit
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
en nog 2

RekruterenFase 3

365 Days – 25 Years · Alle geslachten · Bijgewerkt 25 aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

C S Mott Children's Hospital, Ann Arbor
Children's Hospital of Michigan, Detroit
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
en nog 2

RekruterenFase 1/2

Tot leeftijd 22 · Alle geslachten · Bijgewerkt 25 aug. 2026 · NCT04726241

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

C.S. Mott Children's Hospital, Ann Arbor

RekruterenFase 1

Leeftijden 1 tot 21 · Alle geslachten · Bijgewerkt 6 dec. 2024 · NCT05476770

Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.